Focus Partners Wealth’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.56M Sell
52,816
-9,329
-15% -$622K ﹤0.01% 1098
2026
Q1
$3.91M Buy
62,145
+7,655
+14% +$533K ﹤0.01% 1028
2025
Q4
$3.62M Buy
54,490
+27,152
+99% +$1.76M ﹤0.01% 1080
2025
Q3
$1.84M Buy
27,338
+166
+0.6% +$13.1K ﹤0.01% 1047
2025
Q2
$2.37M Buy
27,172
+19,954
+276% +$1.56M 0.01% 863
2025
Q1
$493K Buy
7,218
+841
+13% +$68.6K ﹤0.01% 1353
2024
Q4
$496K Buy
+6,377
New +$472K ﹤0.01% 1326

Other funds holding DXCM

Focus Partners Wealth's DXCM Position: Q2 2026 in Review

Focus Partners Wealth reduced its DexCom (DXCM) stake by 15% in Q2 2026, selling an estimated $622K and leaving 52,816 shares worth $3.56M. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

Focus Partners Wealth first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.91M in Q1 2026. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Focus Partners Wealth held 52,816 shares of DexCom worth $3.56M as of Q2 2026.
  • Focus Partners Wealth sold 9,329 DexCom shares in Q2 2026, an estimated $622K.
  • DexCom made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #1098 holding.
  • Focus Partners Wealth first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • Focus Partners Wealth's DexCom position peaked at $3.91M in Q1 2026.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.